National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 1 of 1 Research Studies DisplayedMitchell AP, Winn AN, Dusetzina SB
Pharmaceutical industry payments and oncologists' selection of targeted cancer therapies in Medicare beneficiaries.
The authors examined the association between oncologists’ receipt of payments from pharmaceutical manufacturers and drug selection in 2 situations where there are multiple treatment options. They found that, for 3 of the 6 cancer drugs studied, physicians who received general payments were more likely to prescribe the drug marketed by the company that made the payments, with imatinib being a notable exception.
AHRQ-funded; HS000032.
Citation: Mitchell AP, Winn AN, Dusetzina SB .
Pharmaceutical industry payments and oncologists' selection of targeted cancer therapies in Medicare beneficiaries.
JAMA Intern Med 2018 Jun;178(6):854-56. doi: 10.1001/jamainternmed.2018.0776.
.
.
Keywords: Cancer, Medication, Practice Patterns